These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 1281204)
1. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis. Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204 [TBL] [Abstract][Full Text] [Related]
2. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate]. Hirano T; Manabe T; Tobe T Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776 [TBL] [Abstract][Full Text] [Related]
3. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis. Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013 [TBL] [Abstract][Full Text] [Related]
4. Effect of prostaglandin E2 on cellular, lysosomal and mitochondrial fragility in caerulein-induced pancreatitis in rats. Manabe T; Hirano T; Ando K; Yotsumoto F; Tobe T Hepatogastroenterology; 1993 Oct; 40(5):463-6. PubMed ID: 8270235 [TBL] [Abstract][Full Text] [Related]
5. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007. Hirano T; Manabe T; Tobe T Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836 [TBL] [Abstract][Full Text] [Related]
6. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis. Hirano T; Manabe T; Tobe T Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294 [TBL] [Abstract][Full Text] [Related]
7. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis. Hirano T; Manabe T; Yotsumoto F; Ando K; Imanishi K; Tobe T Hepatogastroenterology; 1993 Apr; 40(2):155-8. PubMed ID: 7685311 [TBL] [Abstract][Full Text] [Related]
8. Effect of the oral administration of sepimostat mesilate on cerulein induced acute pancreatitis in rats. Wang ZH; Manabe T; Ohshio G; Hirano T; Okada N; Imamura T; Kawaguchi Y; Yotsumoto F; Yamaki K; Imamura M Arzneimittelforschung; 1995 Oct; 45(10):1082-6. PubMed ID: 8595064 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic injuries in rats with fecal peritonitis: protective effect of a new synthetic protease inhibitor, sepinostat mesilate (FUT-187). Hirano T J Surg Res; 1996 Mar; 61(2):301-6. PubMed ID: 8656599 [TBL] [Abstract][Full Text] [Related]
10. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis. Hirano T; Manabe T J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065 [TBL] [Abstract][Full Text] [Related]
11. [Changes of lysosomal and digestive enzymes in rat caerulein pancreatitis]. Hirano T; Manabe T; Imanishi K; Tobe T Nihon Geka Hokan; 1991 Mar; 60(2):122-34. PubMed ID: 1726396 [TBL] [Abstract][Full Text] [Related]
12. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis. Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838 [TBL] [Abstract][Full Text] [Related]
13. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein. Hirano T; Manabe T; Tobe T J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033 [TBL] [Abstract][Full Text] [Related]
14. [Changes of parotid gland in rat caerulein-induced acute pancreatitis: study on in vitro system]. Hirano T; Manabe T; Tobe T Nihon Geka Hokan; 1990 Jul; 59(4):310-4. PubMed ID: 1718233 [TBL] [Abstract][Full Text] [Related]
15. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123. Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of cyclosporin A on the exocrine pancreas in rats. Hirano T; Manabe T; Printz H; Tobe T Surg Gynecol Obstet; 1992 Dec; 175(6):495-500. PubMed ID: 1280373 [TBL] [Abstract][Full Text] [Related]
17. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis. Dabrowski A; Gabryelewicz A J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457 [TBL] [Abstract][Full Text] [Related]
18. Lysosomal enzyme secretion into pancreatic juice in rats injected with pancreatic secretagogues and augmented secretion after short-term pancreatic duct obstruction. Hirano T Nihon Geka Hokan; 1994 Jan; 63(1):21-35. PubMed ID: 7529987 [TBL] [Abstract][Full Text] [Related]
19. Effect of short-term pancreatico-biliary duct obstruction with intraductal hypertension on subcellular organelle fragility and pancreatic adenylate energy metabolism in rats: protective effect of a new protease inhibitor, E-3123. Hirano T; Manabe T Acta Chir Belg; 1994; 94(2):80-5. PubMed ID: 7517090 [TBL] [Abstract][Full Text] [Related]
20. Effect of hypothermia on pancreatic acinar cells in rats. Hirano T; Manabe T; Calne R; Printz H Nihon Geka Hokan; 1992 Jul; 61(4):320-33. PubMed ID: 1281973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]